R. Michael Bagby

Last updated

Robert Michael Bagby (born 1953) is a Canadian psychologist, senior clinician scientist and director of clinical research at the Centre for Addiction and Mental Health (CAMH). He is a full professor in the Department of Psychiatry, University of Toronto. [1] He became a full professor of psychology at the University of Toronto Scarborough campus in July 2011.

Early research interests revolved around psychology and the law having been educated as a forensic psychologist. He also brought awareness to the personality construct alexithymia by developing the Toronto Alexithymia Scale (TAS-20) to measure its qualities. [2] [3] [4] [5] With the revision of the MMPI-2, Bagby was significantly involved in validating test scores, with a focus on being able to identify individuals feigning and/or malingering mental illness. [6] [7] [8] More recently, he has investigated the possibility that Five factor model personality facets could be used to identify many psychiatric conditions with a focus on dimensional versus a categorical approaches that the DSM-IV takes and the newer DSM-5 is said to emphasize. [9] [10] [11] [12]

Related Research Articles

<span class="mw-page-title-main">Schizoid personality disorder</span> Medical condition

Schizoid personality disorder is a personality disorder characterized by a lack of interest in social relationships, a tendency toward a solitary or sheltered life style, secretiveness, emotional coldness, detachment, and apathy. Affected individuals may be unable to form intimate attachments to others and simultaneously possess a rich and elaborate but exclusively internal fantasy world. Other associated features include stilted speech, a lack of deriving enjoyment from most activities, feeling as though one is an "observer" rather than a participant in life, an inability to tolerate emotional expectations of others, apparent indifference when praised or criticized, a degree of asexuality, and idiosyncratic moral or political beliefs.

<span class="mw-page-title-main">Trait theory</span> Approach to the study of human personality

In psychology, trait theory is an approach to the study of human personality. Trait theorists are primarily interested in the measurement of traits, which can be defined as habitual patterns of behaviour, thought, and emotion. According to this perspective, traits are aspects of personality that are relatively stable over time, differ across individuals, are relatively consistent over situations, and influence behaviour. Traits are in contrast to states, which are more transitory dispositions.

The Minnesota Multiphasic Personality Inventory (MMPI) is a standardized psychometric test of adult personality and psychopathology. Psychologists and other mental health professionals use various versions of the MMPI to help develop treatment plans, assist with differential diagnosis, help answer legal questions, screen job candidates during the personnel selection process, or as part of a therapeutic assessment procedure.

Alexithymia is a neuropsychological phenomenon expressing important difficulties in identifying and describing the experienced emotions by oneself or others. It also involves emotional issues in terms of social attachment and interpersonal relations. There is no scientific agreement whether this neuropsychological phenomenon is a personality trait, a medical symptom or eventually a mental disorder.

<span class="mw-page-title-main">Big Five personality traits</span> Personality model consisting of five broad dimensions

The Big Five personality traits is a suggested taxonomy, or grouping, for personality traits, developed from the 1980s onward in psychological trait theory.

<span class="mw-page-title-main">Paul E. Meehl</span> American psychologist (1920–2003)

Paul Everett Meehl was an American clinical psychologist, Hathaway and Regents' Professor of Psychology at the University of Minnesota, and past president of the American Psychological Association. A Review of General Psychology survey, published in 2002, ranked Meehl as the 74th most cited psychologist of the 20th century, in a tie with Eleanor J. Gibson. Throughout his nearly 60-year career, Meehl made seminal contributions to psychology, including empirical studies and theoretical accounts of construct validity, schizophrenia etiology, psychological assessment, behavioral prediction, and philosophy of science.

A spectrum disorder is a mental disorder that includes a range of linked conditions, sometimes also extending to include singular symptoms and traits. The different elements of a spectrum either have a similar appearance or are thought to be caused by the same underlying mechanism. In either case, a spectrum approach is taken because there appears to be "not a unitary disorder but rather a syndrome composed of subgroups". The spectrum may represent a range of severity, comprising relatively "severe" mental disorders through to relatively "mild and nonclinical deficits".

Somatosensory amplification (SSA) is a tendency to perceive normal somatic and visceral sensations as being relatively intense, disturbing and noxious. It is a common feature of hypochondriasis and is commonly found with fibromyalgia, major depressive disorder, some anxiety disorders, Asperger syndrome, and alexithymia. One common clinical measure of SSA is the Somatosensory Amplification Scale (SSAS).

Amplification is used to describe a judged tendency of a person to amplify physical symptoms based on psychological factors such as anxiety or depression. Distinct interpretations of this type of presentation could be sensory processing disorder involving differences in the way a person reacts to sensory input which is regarded as a pervasive developmental disorder related to the autism spectrum; or there is an alternative psychological concept of 'innate sensitiveness' as a personality trait coined by Carl Jung later developed into the highly sensitive person trait. In one instance where amplification is used as a handle or point of reference or diagnosis it is said "somatosensory amplification refers to the tendency to experience somatic sensation as intense, noxious, and disturbing. What may be a minor 'twinge' or mild 'soreness' to the stoic, is a severe, consuming pain to the amplifier."

<span class="mw-page-title-main">Beck Anxiety Inventory</span>

The Beck Anxiety Inventory (BAI), created by Aaron T. Beck and other colleagues, is a 21-question multiple-choice self-report inventory that is used for measuring the severity of anxiety in adolescents and adults ages 17 and older. The questions used in this measure ask about common symptoms of anxiety that the subject has had during the past week. It is designed for individuals who are of 17 years of age or older and takes 5 to 10 minutes to complete. Several studies have found the Beck Anxiety Inventory to be an accurate measure of anxiety symptoms in children and adults.

‘Functional disorder’ is an umbrella term for a group of recognisable medical conditions which are due to changes to the functioning of the systems of the body rather than due to a disease affecting the structure of the body.

Hospital Anxiety and Depression Scale (HADS) was originally developed by Zigmond and Snaith (1983) and is commonly used by doctors to determine the levels of anxiety and depression that a person is experiencing. The HADS is a fourteen item scale that generates: Seven of the items relate to anxiety and seven relate to depression. Zigmond and Snaith created this outcome measure specifically to avoid reliance on aspects of these conditions that are also common somatic symptoms of illness, for example fatigue and insomnia or hypersomnia. This, it was hoped, would create a tool for the detection of anxiety and depression in people with physical health problems.

The Patient Health Questionnaire (PHQ) is a multiple-choice self-report inventory that is used as a screening and diagnostic tool for mental health disorders of depression, anxiety, alcohol, eating, and somatoform disorders. It is the self-report version of the Primary Care Evaluation of Mental Disorders (PRIME-MD), a diagnostic tool developed in the mid-1990s by Pfizer Inc. The length of the original assessment limited its feasibility; consequently, a shorter version, consisting of 11 multi-part questions - the Patient Health Questionnaire was developed and validated.

Jon Elhai is a professor of clinical psychology at the University of Toledo. Elhai is known for being an expert in the assessment and diagnosis of Posttraumatic stress disorder (PTSD), forensic psychological assessment of PTSD, and detection of fabricated/malingered PTSD; as well as in internet addictions.

Post-traumatic stress disorder (PTSD) is an anxiety disorder that may develop after an individual experiences a traumatic event. In the United States, the Social Security Administration and the Department of Veterans Affairs each offer disability compensation programs that provide benefits for qualified individuals with mental disorders, including PTSD. Because of the substantial benefits available to individuals with a confirmed PTSD diagnosis, which causes occupational impairment, the distinct possibility of Type I errors exists, some of which are due to malingering of PTSD.

The Toronto Alexithymia Scale is a measure of deficiency in understanding, processing, or describing emotions. It was developed in 1986 and later revised, removing some of the items. The current version has twenty statements rated on a five-point Likert scale.

In medicine, insomnia is widely measured using the Athens Insomnia Scale (AIS). AIS was first introduced in the year 2000 by a group of researchers from Athens, Greece to assess the insomnia symptoms in patients with sleep disorders.

The Somatic Symptom Scale - 8 (SSS-8) is a brief self-report questionnaire used to assess somatic symptom burden. It measures the perceived burden of common somatic symptoms. These symptoms were originally chosen to reflect common symptoms in primary care but they are relevant for a large number of diseases and mental disorders. The SSS-8 is a brief version of the popular Patient Health Questionnaire - 15 (PHQ-15).

<span class="mw-page-title-main">General Behavior Inventory</span> Overview of the clinical use of the GBI a clinical assessment for bipolar disorder symptoms.

The General Behavior Inventory (GBI) is a 73-question psychological self-report assessment tool designed by Richard Depue and colleagues to identify the presence and severity of manic and depressive moods in adults, as well as to assess for cyclothymia. It is one of the most widely used psychometric tests for measuring the severity of bipolar disorder and the fluctuation of symptoms over time. The GBI is intended to be administered for adult populations; however, it has been adapted into versions that allow for juvenile populations, as well as a short version that allows for it to be used as a screening test.

The Structured Inventory of Malingered Symptomatology (SIMS) is a 75-item true-false questionnaire intended to measure malingering; that is, intentionally exaggerating or feigning psychiatric symptoms, cognitive impairment, or neurological disorders.

References

  1. "Dr. Michael Bagby". Centre for Addiction and Mental Health . Retrieved 14 July 2010.
  2. Bagby, RM; Taylor, GJ; Parker, JD; Loiselle, C (1990). "Cross-validation of the factor structure of the Toronto Alexithymia Scale". Journal of Psychosomatic Research. 34 (1): 47–51. doi:10.1016/0022-3999(90)90007-q. PMID   2313613.
  3. Taylor, GJ; Bagby, RM; Parker, JD (1992). "The Revised Toronto Alexithymia Scale: some reliability, validity, and normative data". Psychotherapy and Psychosomatics. 57 (1–2): 34–41. doi:10.1159/000288571. PMID   1584897.
  4. Bagby, RM; Parker, JD; Taylor, GJ (January 1994). "The twenty-item Toronto Alexithymia Scale--I. Item selection and cross-validation of the factor structure". Journal of Psychosomatic Research. 38 (1): 23–32. doi:10.1016/0022-3999(94)90005-1. PMID   8126686.
  5. Bagby, RM; Taylor, GJ; Parker, JD (January 1994). "The Twenty-item Toronto Alexithymia Scale--II. Convergent, discriminant, and concurrent validity". Journal of Psychosomatic Research. 38 (1): 33–40. doi:10.1016/0022-3999(94)90006-x. PMID   8126688.
  6. Gillis, JR; Rogers, R; Bagby, RM (August 1991). "Validity of the M Test: simulation-design and natural-group approaches". Journal of Personality Assessment. 57 (1): 130–40. doi:10.1207/s15327752jpa5701_15. PMID   1920026.
  7. Rogers, R; Kropp, PR; Bagby, RM; Dickens, SE (September 1992). "Faking specific disorders: a study of the Structured Interview of Reported Symptoms (SIRS)". Journal of Clinical Psychology. 48 (5): 643–8. doi:10.1002/1097-4679(199209)48:5<643::aid-jclp2270480511>3.0.co;2-2. PMID   1401150.
  8. Bagby, RM; Rogers, R; Buis, T (March 1994). "Malingered and Defensive Response Styles on the MMPI-2: An Examination of Validity Scales". Assessment . 1 (1): 31–8. doi:10.1177/1073191194001001005. PMID   9463497. S2CID   24823628.
  9. Bagby, RM; Schuller, DR; Levitt, AJ; Joffe, RT; Harkness, KL (Jun 5, 1996). "Seasonal and non-seasonal depression and the five-factor model of personality". Journal of Affective Disorders. 38 (2–3): 89–95. doi:10.1016/0165-0327(95)00097-6. PMID   8791178.
  10. Bagby, RM; Bindseil, KD; Schuller, DR; Rector, NA; Young, LT; Cooke, RG; Seeman, MV; McCay, EA; Joffe, RT (May 5, 1997). "Relationship between the five-factor model of personality and unipolar, bipolar and schizophrenic patients". Psychiatry Research. 70 (2): 83–94. doi:10.1016/s0165-1781(97)03096-5. PMID   9194202. S2CID   11612933.
  11. Rector, NA; Hood, K; Richter, MA; Bagby, RM (October 2002). "Obsessive-compulsive disorder and the five-factor model of personality: distinction and overlap with major depressive disorder". Behaviour Research and Therapy. 40 (10): 1205–19. doi:10.1016/s0005-7967(02)00024-4. PMID   12375729.
  12. Rector, NA; Bagby, RM; Huta, V; Ayearst, LE (May 15, 2012). "Examination of the trait facets of the five-factor model in discriminating specific mood and anxiety disorders". Psychiatry Research. 199 (2): 131–9. doi:10.1016/j.psychres.2012.04.027. PMID   22595418. S2CID   5471685.